Eisai Head Urges Drug Pricing Targeted At Each Developing-Nation Market
This article was originally published in PharmAsia News
Executive Summary
Eisai’s president says drug makers should price their drugs nation-by-nation based on the economics of each as a way of increasing demand in new markets by providing market access.